Literature DB >> 53371

Chronic liver disease developing after outbreak of HBsAG-negative hepatitis in haemodialysis unit.

R M Galbraith, A L Eddleston, B Portmann, R Williams, P E Gower.   

Abstract

Chronic liver disease developing after acute hepatitis type B is well documented, but is not thought to occur after acute hepatitis due to other viruses. However, follow-up of 29 patients in a haemodialysis unit who contracted HBsAg-negative acute hepatitis during 1968-70 revealed 8 cases with raised serum-aminotransferase levels dating from that time. Liver biopsy in 7 of these disclosed chronic aggressive hepatitis in 3, of whom 2 had already progressed to advanced cirrhosis. Chronic persistent hepatitis was present in 2 others, and the remaining 2 had non-specific hepatitis in association with massive iron overload. Immunological studies demonstrated a higher frequency of cellular immunity to HBsAg in those who had previously had acute hepatitis than in those who had not, although the prevalence of humoral antibody was similar in the two groups. One possible explanation for these findings is the presence of immunological cross-reaction at a cellular level between the hepatitis B virus and that responsible for the initial outbreak.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53371     DOI: 10.1016/s0140-6736(75)92126-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

1.  Evaluation of first- and second-generation RIBA kits for detection of antibody to hepatitis C virus.

Authors:  R K Chaudhary; C MacLean
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

2.  Survival in 200 patients treated by haemodialysis and renal transplantation.

Authors:  F Z Henari; P E Gower; J R Curtis; J B Eastwood; M E Phillips; M L Greatbatch; G B Williams; E M Gordon; P J Boyd; R K Stubbs; H E de Wardener
Journal:  Br Med J       Date:  1977-02-12

3.  Paracetamol overdose as a cause of non-A, non-B hepatitis.

Authors:  C L Leen; P D Welsby
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-07

4.  Viral hepatitis A and B in hemodialysed patients.

Authors:  K Gmelin; B von Ehrlich; B Kommerell; E Ritz; J Bommer
Journal:  Klin Wochenschr       Date:  1980-04-01

5.  Non-A non-B hepatitis.

Authors: 
Journal:  Br Med J       Date:  1978-04-15

6.  Antibody to hepatitis C virus in risk groups in Canada.

Authors:  R Chaudhary; T Mo
Journal:  Can J Infect Dis       Date:  1992-01

7.  Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland.

Authors:  P J Conlon; J J Walshe; E G Smyth; E B McNamara; J Donohoe; M Carmody
Journal:  Ir J Med Sci       Date:  1993-04       Impact factor: 1.568

8.  Hepatitis non-A, non-B.

Authors:  C V Feinman; B Berris; J C Sinclair; D Wrobel
Journal:  Can Med Assoc J       Date:  1980-08-09       Impact factor: 8.262

9.  Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation.

Authors:  P Baur; V Daniel; S Pomer; H Scheurlen; G Opelz; D Roelcke
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

10.  Hepatitis in dialysis units in the United Kingdom: a Public Health Laboratory Service Survey.

Authors:  S Polakoff
Journal:  J Hyg (Lond)       Date:  1981-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.